229 related articles for article (PubMed ID: 35438552)
1. Probiotic Characterization of
Lee Y; Kim N; Werlinger P; Suh DA; Lee H; Cho JH; Cheng J
J Med Food; 2022 Apr; 25(4):367-380. PubMed ID: 35438552
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis.
Wang H; Mei L; Deng Y; Liu Y; Wei X; Liu M; Zhou J; Ma H; Zheng P; Yuan J; Li M
Nutrition; 2019 Jun; 62():63-73. PubMed ID: 30852460
[TBL] [Abstract][Full Text] [Related]
3. Potential Probiotic
Lee Y; Werlinger P; Suh JW; Cheng J
Microorganisms; 2022 Apr; 10(5):. PubMed ID: 35630296
[TBL] [Abstract][Full Text] [Related]
4. Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats.
Li M; Yang D; Mei L; Yuan L; Xie A; Yuan J
PLoS One; 2014; 9(9):e105577. PubMed ID: 25184445
[TBL] [Abstract][Full Text] [Related]
5.
Kuo YW; Hsieh SH; Chen JF; Liu CR; Chen CW; Huang YF; Ho HH
PeerJ; 2021; 9():e11209. PubMed ID: 33986988
[TBL] [Abstract][Full Text] [Related]
6.
Hussain A; Rui B; Ullah H; Dai P; Ahmad K; Yuan J; Liu Y; Li M
Microorganisms; 2024 Mar; 12(4):. PubMed ID: 38674582
[TBL] [Abstract][Full Text] [Related]
7. The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice.
Kodithuwakku ND; Feng YD; Zhang YY; Pan M; Fang WR; Li YM
J Ethnopharmacol; 2015 Apr; 163():278-89. PubMed ID: 25614106
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of purine-nucleoside degrading ability and in vivo uric acid lowering of Streptococcus thermophilus IDCC 2201, a novel antiuricemia strain.
Kim D; Moon JS; Kim JE; Jang YJ; Choi HS; Oh I
PLoS One; 2024; 19(2):e0293378. PubMed ID: 38386624
[TBL] [Abstract][Full Text] [Related]
9. Anaerobic purinolytic enzymes enable dietary purine clearance by engineered gut bacteria.
Tong Y; Wei Y; Ju Y; Li P; Zhang Y; Li L; Gao L; Liu S; Liu D; Hu Y; Li Z; Yu H; Luo Y; Wang J; Wang Y; Zhang Y
Cell Chem Biol; 2023 Sep; 30(9):1104-1114.e7. PubMed ID: 37164019
[TBL] [Abstract][Full Text] [Related]
10.
Cao J; Liu Q; Hao H; Bu Y; Tian X; Wang T; Yi H
Front Immunol; 2022; 13():940228. PubMed ID: 35874662
[TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
[TBL] [Abstract][Full Text] [Related]
12. Flavonoids and phenylethanoid glycosides from Lippia nodiflora as promising antihyperuricemic agents and elucidation of their mechanism of action.
Cheng LC; Murugaiyah V; Chan KL
J Ethnopharmacol; 2015 Dec; 176():485-93. PubMed ID: 26593216
[TBL] [Abstract][Full Text] [Related]
13. The anti-hyperuricemic and gut microbiota regulatory effects of a novel purine assimilatory strain, Lactiplantibacillus plantarum X7022.
Zou Y; Ro KS; Jiang C; Yin D; Zhao L; Zhang D; Du L; Xie J
Eur J Nutr; 2024 Apr; 63(3):697-711. PubMed ID: 38147149
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological effects of Chatuphalatika in hyperuricemia of gout.
Sato VH; Sungthong B; Rinthong PO; Nuamnaichati N; Mangmool S; Chewchida S; Sato H
Pharm Biol; 2018 Dec; 56(1):76-85. PubMed ID: 29298537
[TBL] [Abstract][Full Text] [Related]
15. Screening of lactic acid bacteria strains with urate-lowering effect from fermented dairy products.
Zhu J; Li Y; Chen Z; Gao K; Lin G; Chen S; Li L; Ge H
J Food Sci; 2022 Nov; 87(11):5118-5127. PubMed ID: 36250495
[TBL] [Abstract][Full Text] [Related]
16. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
Lü JM; Yao Q; Chen C
Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
[TBL] [Abstract][Full Text] [Related]
17. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
[TBL] [Abstract][Full Text] [Related]
18.
Wu Y; Ye Z; Feng P; Li R; Chen X; Tian X; Han R; Kakade A; Liu P; Li X
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33764849
[TBL] [Abstract][Full Text] [Related]
19. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation.
Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL
Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446
[TBL] [Abstract][Full Text] [Related]
20.
Shi R; Ye J; Fan H; Xiao C; Wang D; Xia B; Zhao Z; Zhao B; Dai X; Liu X
Food Funct; 2023 Jun; 14(12):5663-5677. PubMed ID: 37264705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
